Literature DB >> 5768460

Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation.

A D Wright, E M Kohner, N W Oakley, M Hartog, G F Joplin, T R Fraser.   

Abstract

Serum growth hormone levels were measured during insulin tolerance tests in 36 patients after yttrium-90 pituitary implantation for diabetic retinopathy. The response of the new blood vessels was more clearly related to loss of growth hormone function than was the improvement of retinal haemorrhages and microaneurysms. The overall response of the retinopathy was greatest when growth hormone function was lost.Since the loss of growth hormone function was related to the loss of other aspects of anterior pituitary function, a unique role of growth hormone in the response of diabetic retinopathy to pituitary ablation could not be established.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5768460      PMCID: PMC1983255          DOI: 10.1136/bmj.2.5653.346

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  The effect of hypophyseal stalk section on advancing diabetic retinopathy. Report of thirteen cases.

Authors:  R A FIELD; C L SCHEPENS; W H SWEET; A APPELS
Journal:  Diabetes       Date:  1962 Nov-Dec       Impact factor: 9.461

2.  The use of hypophysectomy in juvenile diabetes mellitus with vascular complications.

Authors:  R LUFT
Journal:  Diabetes       Date:  1962 Nov-Dec       Impact factor: 9.461

3.  The significance of endocrine activity in hypophysectomized diabetics.

Authors:  A Teuscher; S Fankhauser; J Girard; F Wyss
Journal:  Helv Med Acta       Date:  1966-04

4.  Hypophysectomy for the treatment of advanced diabetic retinopathy.

Authors:  S Fankhauser; A Teuscher; H König; F Reubi
Journal:  Helv Med Acta       Date:  1966-04

5.  Pituitary ablation for diabetic retinopathy. I. Results of hypophysectomy. (A ten-year evaluation).

Authors:  B S Ray; A G Pazianos; E Greenberg; W L Peretz; J M McLean
Journal:  JAMA       Date:  1968-01-08       Impact factor: 56.272

6.  Standard procedures for assessing hypersecretion or secretory capacity for human growth hormone, using the radioimmunoassay.

Authors:  R Fraser; A D Wright
Journal:  Postgrad Med J       Date:  1968-01       Impact factor: 2.401

7.  Diabetic retinopathy. I. The assessment of severity and progress by comparison with a set of standard fundus photographs.

Authors:  N Oakley; D W Hill; G F Joplin; E M Kohner; T R Fraser
Journal:  Diabetologia       Date:  1967-08       Impact factor: 10.122

8.  Diabetic retinopathy. II. Comparison of disease remission induced by various degrees of pituitary ablation by Y90.

Authors:  G F Joplin; N W Oakley; D W Hill; E M Kohner; T R Fraser
Journal:  Diabetologia       Date:  1967-08       Impact factor: 10.122

9.  Growth hormone in relation to diabetic retinopathy.

Authors:  E D Powell; A G Frantz; M T Rabkin; R A Field
Journal:  N Engl J Med       Date:  1966-10-27       Impact factor: 91.245

10.  Pituitary ablation for diabetic retinopathy.

Authors:  G F Joplin; R Fraser; D W Hill; N W Oakley; D J Scott
Journal:  Q J Med       Date:  1965-10
View more
  10 in total

1.  Effect of pituitary ultrasonic treatment on plasma human growth hormone levels in diabetic retinopathy and acromegaly.

Authors:  M Muggeo; M Molinari; D Fedele; A Tiengo; G Crepaldi
Journal:  Acta Diabetol Lat       Date:  1975 Mar-Apr

Review 2.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

3.  Plasma growth hormone response to insulin-induced hypoglycemia in diabetes mellitus.

Authors:  M K Sinha; G P Malik; G K Rastogi
Journal:  Acta Diabetol Lat       Date:  1974 Mar-Apr

Review 4.  Human pituitary disease.

Authors:  R Fraser
Journal:  Br Med J       Date:  1970-11-21

5.  Cutaneous capillary resistance and retinal haemorrhage in diabetes.

Authors:  P R Hunter; A Bloom; J H Kelsey; R Porter
Journal:  Diabetologia       Date:  1971-02       Impact factor: 10.122

6.  Growth hormone response to L-dopa in diabetes mellitus.

Authors:  V Sekhuja; G K Rastogi; R Sialy
Journal:  Acta Diabetol Lat       Date:  1976 Sep-Dec

7.  Fate of insulin in the retina: an autoradiographic study.

Authors:  C R James; E Cotlier
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

Review 8.  IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

Authors:  Raffael Liegl; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Early Hum Dev       Date:  2016-09-17       Impact factor: 2.079

9.  Serum insulin-like growth factor-I in diabetic retinopathy.

Authors:  John F Payne; Vin Tangpricha; Julia Cleveland; Michael J Lynn; Robin Ray; Sunil K Srivastava
Journal:  Mol Vis       Date:  2011-08-27       Impact factor: 2.367

10.  Choroidal neovascularization in patient undergoing growth hormone treatment.

Authors:  João R de Oliveira Dias; Eduardo B Rodrigues; Maurício Martinazzo; Michel E Farah
Journal:  Clin Ophthalmol       Date:  2009-06-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.